Skip to content

bone marrow sample

BIOLOGICAL6 trials

Sponsors

University Hospital, Toulouse, Central Hospital, Nancy, France, University Hospital, Bordeaux, Centre Hospitalier Universitaire, Amiens, Gustave Roussy, Cancer Campus, Grand Paris

Conditions

Acute Myeloid LeukemiaAllogeneic Stem Cell TransplantationHematologic CancerHyperviscosity SyndromeImmune Evasion, TumorMyelodysplastic SyndromesPurpura, ThrombocytopenicRelapse Leukemia

Unknown Phase

Study of Dendrogenin A / Oxysterols Balance Between Healthy Volunteers and Acute Myeloid Leukemia Patients
CompletedNCT02602587
University Hospital, ToulouseAcute Myeloid Leukemia
Start: 2014-11-25End: 2018-11-20Updated: 2019-05-13
Immunoevasive Tactics Employed by Myeloid Malignancy After Allogeneic Stem Cell Transplantation
NCT03964922
Central Hospital, Nancy, FranceAllogeneic Stem Cell Transplantation, Immune Evasion, Tumor, Relapse Leukemia
Start: 2019-09-01End: 2022-11-01Target: 104Updated: 2019-05-28
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220
University Hospital, BordeauxMyelodysplastic Syndromes, Purpura, Thrombocytopenic, Thrombocytopenia
Start: 2020-09-07End: 2023-09-07Target: 80Updated: 2022-11-28
Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia
RecruitingNCT04893564
Centre Hospitalier Universitaire, AmiensWaldenstrom Macroglobulinemia, Waldenstrom's Disease
Start: 2022-05-16End: 2028-07-31Target: 90Updated: 2025-09-09
Clinical Study of the Hyperviscosity Syndrome in Waldenström Macroglobulinemia
RecruitingNCT04898647
Centre Hospitalier Universitaire, AmiensHyperviscosity Syndrome, Waldenstrom Macroglobulinemia
Start: 2021-05-14End: 2026-08-31Target: 100Updated: 2025-05-29
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors
RecruitingNCT05481502
Gustave Roussy, Cancer Campus, Grand ParisHematologic Cancer, Solid Tumor, Adult, Solid Tumor, Childhood
Start: 2022-06-08End: 2027-07-01Target: 160Updated: 2025-06-24

Related Papers